Situation Report

Pfizer and its partner BioNTech said Thursday they are beginning a study to test whether a third shot of their COVID-19 vaccine will help protect against variants of the virus.

Country / Region Tags:

Germany

Global

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer to study using booster shot aimed at virus variant
Log in or register to post comments

Moderna developing booster shot for coronavirus variants, boosts production target

Wed, 2021-02-24 17:42 — mike kraft

Moderna developing booster shot for new coronavirus variants, increases vaccine production target Moderna Inc said on Wednesday it is working with U.S. government scientists to study an experimental booster shot that targets a concerning new variant of the coronavirus, and has raised its global COVID-19 vaccine production goal for this year by 100 million doses. Julie Steenhuysen, Carl O’Donnell U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Moderna developing booster shot for coronavirus variants, boosts production target
Log in or register to post comments

NIH to launch research into Covid long term effects, plus international roundup

Wed, 2021-02-24 13:16 — mike kraft

Roundup: NIH to study ‘long-haul’ virus symptoms

WASHINGTON (AP) — The National Institutes of Health is launching research to understand the causes and consequences of the lingering brain fog, breathing problems and malaise reported by many recovering COVID-19 patients.

Dr. Anthony Fauci says some studies have shown up to 30% of patients report symptoms that can endure for months, complicating their return to normal routines and work, and plunging many recovering patients into depression.

Fauci noted at a White House coronavirus briefing on Wednesday that work at NIH started this week thanks to more than $1 billion provided by Congress for COVID-related medical research. Government scientists are looking to enlist doctors and research institutions around the country in the effort to learn about “long-haul” COVID-19.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about NIH to launch research into Covid long term effects, plus international roundup
Log in or register to post comments

Germany approves COVID home tests to help ease the lockdown

Wed, 2021-02-24 10:26 — mike kraft

Germany approves COVID home tests to ease way out of lockdown Germany approved three COVID-19 tests for home use as part Health Minister Jens Spahn's strategy to help Europe's biggest economy emerge from a lockdown that has been in place since mid-December. Reuters Staff U.S.

BERLIN (Reuters) - Germany approved three COVID-19 tests for home use as part Health Minister Jens Spahn’s strategy to help Europe’s biggest economy emerge from a lockdown that has been in place since mid-December.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Germany approves COVID home tests to help ease the lockdown
Log in or register to post comments

New coronavirus mutant found in California is more contagious

Wed, 2021-02-24 09:23 — mike kraft

What we know about California COVID variant B.1.427/ B.1.429 Researchers from the University of California, San Francisco, say it should be listed as a "variant of concern." Newsweek

A new coronavirus variant that was first identified in California is now taking hold in some parts of the state—but what do we currently know about it?

The variant actually comes in two forms, known as B.1.427 and B.1.429, both of which carry a similar, albeit slightly differing, set of genetic mutations—including three that affect the spike protein of the SARS-CoV-2 virus.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about New coronavirus mutant found in California is more contagious
Log in or register to post comments

FDA says Johnson and Johnson vaccine provides protection against Covid, a step toward final decision

Wed, 2021-02-24 09:09 — mike kraft

FDA says J&J 1-dose shot prevents COVID; final decision soon

WASHINGTON (AP) — Johnson & Johnson’s single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.

The Food and Drug Administration’s scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. The agency also said J&J’s shot — one that could help speed vaccinations by requiring just one dose instead of two — is safe to use.

That’s just one step in the FDA’s evaluation of a third vaccine option for the U.S. On Friday, the agency’s independent advisers will debate if the evidence is strong enough to recommend the long-anticipated shot. Armed with that advice, FDA is expected to make a final decision within days. ...

Country / Region Tags:

General Topic Tags: